We identify a mutation in the c-fos promoter, a gene of the AP-1 transcription factor family, in a patient with congenital generalized lipodystrophy, hepatic steatosis, severe dyslipidemia, and insulin resistance. The gene discussed is FOS; the disease is generalized lipodystrophy.